enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
3.250
-0.120 (-3.56%)
Nov 21, 2024, 1:21 PM EST - Market open
enVVeno Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 57 | 68 | 48 | 62 | 19 | 10 | |
Market Cap Growth | 15.41% | 41.69% | -22.58% | 222.87% | 96.05% | -42.97% | |
Enterprise Value | 12 | 44 | 10 | 5 | 15 | 8 | |
Last Close Price | 3.37 | 5.14 | 5.10 | 6.59 | 8.65 | 13.75 | |
PS Ratio | - | - | - | - | - | 315.50 | |
PB Ratio | 1.25 | 1.48 | 1.25 | 1.15 | 2.72 | 9.96 | |
P/TBV Ratio | 1.24 | 1.48 | 1.25 | 1.15 | 2.72 | 9.96 | |
EV/Sales Ratio | - | - | - | - | - | 250.83 | |
Debt / Equity Ratio | 0.02 | 0.03 | 0.04 | 0.04 | 0.12 | 0.87 | |
Asset Turnover | - | - | - | - | - | 0.01 | |
Quick Ratio | 21.70 | 33.85 | 25.52 | 34.64 | 2.93 | 0.70 | |
Current Ratio | 22.01 | 34.23 | 25.78 | 34.84 | 3.00 | 0.76 | |
Return on Equity (ROE) | -58.76% | -55.38% | -52.98% | -53.75% | -225.91% | -503.93% | |
Return on Assets (ROA) | -37.28% | -34.94% | -31.37% | -30.95% | -81.73% | -126.66% | |
Return on Capital (ROIC) | -39.05% | -35.83% | -32.18% | -32.80% | -116.22% | -228.12% | |
Earnings Yield | -35.94% | -34.36% | -51.07% | -26.49% | -47.27% | -77.36% | |
FCF Yield | -28.33% | -27.60% | -32.57% | -19.58% | -40.66% | -63.51% | |
Buyback Yield / Dilution | -68.13% | -29.87% | -9.12% | -572.10% | -104.86% | -68.34% | |
Total Shareholder Return | -68.13% | -29.87% | -9.12% | -572.10% | -104.86% | -68.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.